APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genito-Urinary Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genito-Urinary Drugs Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchGenito-Urinary Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Genito-Urinary Drugs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Genito-Urinary Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genito-Urinary Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Genito-Urinary Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Genito-Urinary Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genito-Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genito-Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genito-Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genito-Urinary Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genito-Urinary Drugs market include Sanofi, Pfizer, GSK, Bayer, AbbVie, Otsuka Pharmaceutical, Daiichi Sankyo Company and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genito-Urinary Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genito-Urinary Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genito-Urinary Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genito-Urinary Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Genito-Urinary Drugs Segment by Company

Sanofi

Pfizer

GSK

Bayer

AbbVie

Otsuka Pharmaceutical

Daiichi Sankyo Company

Astellas Pharma

Genito-Urinary Drugs Segment by Type

OTC

Rx Drugs

Genito-Urinary Drugs Segment by Application

Hospital

Drugs Store

Other

Genito-Urinary Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Genito-Urinary Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Genito-Urinary Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genito-Urinary Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Genito-Urinary Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genito-Urinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genito-Urinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genito-Urinary Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genito-Urinary Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genito-Urinary Drugs industry.

Chapter 3: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Genito-Urinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Genito-Urinary Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genito-Urinary Drugs Industry Trends Table 2. Genito-Urinary Drugs Industry Drivers Table 3. Genito-Urinary Drugs Industry Opportunities and Challenges Table 4. Genito-Urinary Drugs Industry Restraints Table 5. Global Genito-Urinary Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genito-Urinary Drugs Revenue Share by Company (2021-2026) Table 7. Global Genito-Urinary Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Genito-Urinary Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Genito-Urinary Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Genito-Urinary Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Genito-Urinary Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Genito-Urinary Drugs Company, Product Type & Application Table 13. Global Genito-Urinary Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Genito-Urinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of OTC Table 18. Significant Companies of Rx Drugs Table 19. Global Genito-Urinary Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Genito-Urinary Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Genito-Urinary Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Genito-Urinary Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Genito-Urinary Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Genito-Urinary Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Genito-Urinary Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Genito-Urinary Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Genito-Urinary Drugs Sales Value Share by Type (2021-2026) Table 28. Global Genito-Urinary Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drugs Store Table 31. Significant Companies of Other Table 32. Global Genito-Urinary Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Genito-Urinary Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Genito-Urinary Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Genito-Urinary Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Genito-Urinary Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Genito-Urinary Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Genito-Urinary Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Genito-Urinary Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Genito-Urinary Drugs Sales Value Share by Application (2021-2026) Table 41. Global Genito-Urinary Drugs Sales Value Share by Application (2027-2032) Table 42. Global Genito-Urinary Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Genito-Urinary Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Genito-Urinary Drugs Sales Market Share by Region (2021-2026) Table 45. Global Genito-Urinary Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Genito-Urinary Drugs Sales Market Share by Region (2027-2032) Table 47. Global Genito-Urinary Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Genito-Urinary Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Genito-Urinary Drugs Sales Value Share by Region (2021-2026) Table 50. Global Genito-Urinary Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Genito-Urinary Drugs Sales Value Share by Region (2027-2032) Table 52. Global Genito-Urinary Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Genito-Urinary Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Genito-Urinary Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Genito-Urinary Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Genito-Urinary Drugs Sales Market Share by Country (2021-2026) Table 58. Global Genito-Urinary Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Genito-Urinary Drugs Sales Market Share by Country (2027-2032) Table 60. Global Genito-Urinary Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Genito-Urinary Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Genito-Urinary Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Genito-Urinary Drugs Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Genito-Urinary Drugs Product Portfolio Table 68. Sanofi Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Pfizer Genito-Urinary Drugs Product Portfolio Table 73. Pfizer Recent Development Table 74. GSK Company Information Table 75. GSK Business Overview Table 76. GSK Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GSK Genito-Urinary Drugs Product Portfolio Table 78. GSK Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bayer Genito-Urinary Drugs Product Portfolio Table 83. Bayer Recent Development Table 84. AbbVie Company Information Table 85. AbbVie Business Overview Table 86. AbbVie Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AbbVie Genito-Urinary Drugs Product Portfolio Table 88. AbbVie Recent Development Table 89. Otsuka Pharmaceutical Company Information Table 90. Otsuka Pharmaceutical Business Overview Table 91. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio Table 93. Otsuka Pharmaceutical Recent Development Table 94. Daiichi Sankyo Company Company Information Table 95. Daiichi Sankyo Company Business Overview Table 96. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio Table 98. Daiichi Sankyo Company Recent Development Table 99. Astellas Pharma Company Information Table 100. Astellas Pharma Business Overview Table 101. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Astellas Pharma Genito-Urinary Drugs Product Portfolio Table 103. Astellas Pharma Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Genito-Urinary Drugs Distributors List Table 107. Genito-Urinary Drugs Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Genito-Urinary Drugs Product Image Figure 2. Global Genito-Urinary Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genito-Urinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Genito-Urinary Drugs Sales (2021-2032) & (K Units) Figure 5. Global Genito-Urinary Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Genito-Urinary Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. OTC Image Figure 10. Rx Drugs Image Figure 11. Global Genito-Urinary Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Genito-Urinary Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Genito-Urinary Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Genito-Urinary Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Genito-Urinary Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Genito-Urinary Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drugs Store Image Figure 19. Other Image Figure 20. Global Genito-Urinary Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Genito-Urinary Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Genito-Urinary Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Genito-Urinary Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Genito-Urinary Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Genito-Urinary Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Genito-Urinary Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Genito-Urinary Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Genito-Urinary Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Genito-Urinary Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Genito-Urinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Genito-Urinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Genito-Urinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Genito-Urinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Genito-Urinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Genito-Urinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Genito-Urinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Genito-Urinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Genito-Urinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Genito-Urinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Genito-Urinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Genito-Urinary Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Genito-Urinary Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Rx Drugs
Applications
  • Hospital
  • Drugs Store
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • GSK
  • Bayer
  • AbbVie
  • Otsuka Pharmaceutical
  • Daiichi Sankyo Company
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genito-Urinary Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Genito-Urinary Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Genito-Urinary Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Genito-Urinary Drugs Market Dynamics
  1. 2.1 Genito-Urinary Drugs Industry Trends
  2. 2.2 Genito-Urinary Drugs Industry Drivers
  3. 2.3 Genito-Urinary Drugs Industry Opportunities and Challenges
  4. 2.4 Genito-Urinary Drugs Industry Restraints
3 Genito-Urinary Drugs Market by Company
  1. 3.1 Global Genito-Urinary Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Genito-Urinary Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Genito-Urinary Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Genito-Urinary Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Genito-Urinary Drugs Company Ranking (2024-2026)
  6. 3.6 Global Genito-Urinary Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Genito-Urinary Drugs Company Product Type and Application
  8. 3.8 Global Genito-Urinary Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Genito-Urinary Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Genito-Urinary Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Genito-Urinary Drugs Market by Type
  1. 4.1 Genito-Urinary Drugs Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 Rx Drugs
  4. 4.2 Global Genito-Urinary Drugs Sales Volume by Type
  5. 4.2.1 Global Genito-Urinary Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Genito-Urinary Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Genito-Urinary Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Genito-Urinary Drugs Sales Value by Type
  9. 4.3.1 Global Genito-Urinary Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Genito-Urinary Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Genito-Urinary Drugs Sales Value Share by Type (2021-2032)
5 Genito-Urinary Drugs Market by Application
  1. 5.1 Genito-Urinary Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.1.3 Other
  5. 5.2 Global Genito-Urinary Drugs Sales Volume by Application
  6. 5.2.1 Global Genito-Urinary Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Genito-Urinary Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Genito-Urinary Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Genito-Urinary Drugs Sales Value by Application
  10. 5.3.1 Global Genito-Urinary Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Genito-Urinary Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Genito-Urinary Drugs Sales Value Share by Application (2021-2032)
6 Genito-Urinary Drugs Regional Sales and Value Analysis
  1. 6.1 Global Genito-Urinary Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genito-Urinary Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Genito-Urinary Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Genito-Urinary Drugs Sales by Region (2027-2032)
  5. 6.3 Global Genito-Urinary Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Genito-Urinary Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Genito-Urinary Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Genito-Urinary Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Genito-Urinary Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Genito-Urinary Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Genito-Urinary Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Genito-Urinary Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Genito-Urinary Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Genito-Urinary Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Genito-Urinary Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Genito-Urinary Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Genito-Urinary Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Genito-Urinary Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Genito-Urinary Drugs Sales Value Share by Country, 2025 VS 2032
7 Genito-Urinary Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genito-Urinary Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Genito-Urinary Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Genito-Urinary Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Genito-Urinary Drugs Sales by Country (2027-2032)
  6. 7.4 Global Genito-Urinary Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Genito-Urinary Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Genito-Urinary Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Genito-Urinary Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Genito-Urinary Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Genito-Urinary Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Genito-Urinary Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Genito-Urinary Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GSK Genito-Urinary Drugs Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Genito-Urinary Drugs Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 AbbVie
  26. 8.5.1 AbbVie Company Information
  27. 8.5.2 AbbVie Business Overview
  28. 8.5.3 AbbVie Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Genito-Urinary Drugs Product Portfolio
  30. 8.5.5 AbbVie Recent Developments
  31. 8.6 Otsuka Pharmaceutical
  32. 8.6.1 Otsuka Pharmaceutical Company Information
  33. 8.6.2 Otsuka Pharmaceutical Business Overview
  34. 8.6.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio
  36. 8.6.5 Otsuka Pharmaceutical Recent Developments
  37. 8.7 Daiichi Sankyo Company
  38. 8.7.1 Daiichi Sankyo Company Company Information
  39. 8.7.2 Daiichi Sankyo Company Business Overview
  40. 8.7.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio
  42. 8.7.5 Daiichi Sankyo Company Recent Developments
  43. 8.8 Astellas Pharma
  44. 8.8.1 Astellas Pharma Company Information
  45. 8.8.2 Astellas Pharma Business Overview
  46. 8.8.3 Astellas Pharma Genito-Urinary Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Astellas Pharma Genito-Urinary Drugs Product Portfolio
  48. 8.8.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genito-Urinary Drugs Value Chain Analysis
  2. 9.1.1 Genito-Urinary Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genito-Urinary Drugs Sales Mode & Process
  6. 9.2 Genito-Urinary Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genito-Urinary Drugs Distributors
  9. 9.2.3 Genito-Urinary Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst